Signifier meets CMS requirements for reimbursement
By HME News Staff
Updated 8:45 AM CDT, Mon March 10, 2025
LONDON – Signifier Medical Technologies Limited has introduced its newest SKU, 18010, which features a hardware remote control specifically designed to meet CMS requirements for reimbursement. The company says the development ensures that its eXciteOSA therapy can be more readily accessible for Medicare and Medicaid beneficiaries. “eXciteOSA is a life-changing device helping patients address a root cause of sleep apnea and other sleep disorders,” said Mujtaba Chohan, head of finance and director at Signifier. “This milestone underscores our ongoing commitment to innovation, as well as our determination to expand treatment access through alignment with CMS requirements. Today’s announcement is a testament to the collaborative efforts of our multidisciplinary teams, and I am proud of the progress we’ve made in ensuring that these therapies are available and affordable to as many people as possible.” By introducing this hardware remote control, Signifier has met the criteria to classify its eXciteOSA therapy under CMS HCPCS Codes (E0490 and E0491). The company says the remote control simplifies device usage for patients, offering a user-friendly interface that aligns with the DME requirements set forth by Medicare and Medicaid. It also maintains the same clinically proven efficacy and convenience.
Comments